Area of research
Oncology · Immunology
Research interest
Research interests include CAR-T cell therapy research, Virus-based gene therapy research, Biosimilars and Bioanalytical Methods, and Immunotherapy and Immune Responses.
Effects of an Initial Anti-CD19 CAR T-cell Therapy on Subsequent Anti-CD22 CAR T-cell Manufacturing and Clinical Outcomes in Patients with Relapsed/Refractory LBCL
Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas
Author Correction: Intravenous and intracranial GD2-CAR T cells for H3K27M+ diffuse midline gliomas
Abstract 1158: Inosine endows CAR T cells with features of increased stemness and anti-tumor potency
Enhanced safety and efficacy of protease-regulated CAR-T cell receptors
Enhanced T cell effector activity by targeting the Mediator kinase module
Transient rest restores functionality in exhausted CAR-T cells through epigenetic remodeling
GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity
Global analysis of shared T cell specificities in human non-small cell lung cancer enables HLA inference and antigen discovery
Glutamine-dependent α-ketoglutarate production regulates the balance between T helper 1 cell and regulatory T cell generation